Drugs / RO7837195
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06979336 | Sep 2025 → Aug 2027 expected | ulcerative colitis | Genentech, Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7837195 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06979336 ↗ |